Medisolv Acquires Health Elements AI to Automate Clinical Data Abstraction and Quality Reporting
Behind every quality score in healthcare, a human chain of clicks, judgment calls, and late-night reconciliations keeps the system moving, even when it feels like it’s dragging its own weight uphill.
Medisolv, Inc. looked at that friction and decided it wasn’t a cost of doing business, it was a signal worth chasing, which is exactly why David Lucey, Jr., CEO, and Dustin Wolfe, CTO, just made a move that feels less like an acquisition and more like a recalibration as Medisolv brings Health Elements AI into the fold, pulling AI-driven abstraction directly into a system that already touches 1,800+ healthcare organizations, 15,000+ providers, and north of 140 million patient records, a level of reach where this kind of integration stops being incremental and starts becoming foundational.
Credit where it’s due because Jeff LeBrun, CEO, and Russell Authur, CTO, didn’t build a feature, they built leverage, spinning Health Elements AI out of the Allen Institute for AI with a reported 96% abstraction accuracy rate paired with human oversight, which in plain terms means the machine handles the repetition while the human protects the integrity, and that balance is exactly where real adoption lives, far away from polished demos and right inside workflows that have to perform under pressure every single day.
Medisolv has been setting this table for a while, with Zahid W. Butt, MD, FACG laying the foundation back in 1999 on the belief that better data drives better outcomes, and today ENCOR operates less like a product and more like infrastructure with daily data refreshes, deep integrations across Epic, Cerner, Meditech and others, and a footprint covering roughly a quarter of U.S. hospitals, so when AI-powered abstraction drops into that environment it doesn’t just speed things up, it changes how the entire system processes, interprets, and acts on clinical data.
The timing carries weight because healthcare continues to bleed somewhere between $250B and $1T annually on administrative overhead depending on who’s running the math, and while manual abstraction isn’t the villain of that story it certainly isn’t the hero, which makes upstream automation more than a productivity gain since it directly reshapes how quality is measured, reported, and ultimately tied to reimbursement in a system that increasingly rewards precision.
A pattern is emerging in plain sight as Lilac Software came into the picture in March to expand into Medicare Advantage and HEDIS analytics, followed by Health Elements AI in April to take ownership of abstraction, signaling that this is less about expansion for the sake of growth and more about building connective tissue across payer, provider, and registry ecosystems so data can finally move with intention instead of resistance.
And then there’s the quiet flex that doesn’t need a billboard, no client penalties tied to missed submissions, which in a compliance-heavy environment says more about operational discipline than any marketing line ever could, especially when the stakes are tied directly to financial outcomes and regulatory scrutiny.
So the conversation shifts because whether AI belongs in clinical quality workflows is already settled, and what actually matters now is what happens when abstraction, analytics, and submission start operating in sync, in real time, without the usual lag and friction that have defined the space for decades, because once the data stops stuttering, everything downstream starts to move with a different kind of clarity.
